Indian Patent Law | Intellepedia

Patent: Basics of Specification Drafting – Presentation by Somashekar Ramakrishna

[slideshare id=45409802&doc=basicsofspecificationdrafting-150304014411-conversion-gate01] The presentation herein, on Basics of Specification Drafting, was delivered by Mr. Somashekar Ramakrishna at the National Law School of India University, Bangalore, for...

Presentation on Patent Infringement Analysis by Dr. Kalyan

[slideshare id=45407242&doc=patentinfringementanalysis-150304000311-conversion-gate01] The presentation herein, on patent infringement analysis, is delivered by Dr. Kalyan Kankanala at the National Law School of India University, Bangalore, for...

Is Criteria to Determine Obviousness in Patent Still Ambiguous?

The post discusses the persistent ambiguity in the legal criteria for determining obviousness in patent matters. It assesses recent judicial trends and the impact of landmark cases like KSR v Teleflex, noting the continued subjectivity in evaluating inventive step in India.

Special 301 Report: Chapter V. Inventive Step & 3(d) – Comprehending Apprehension or Apprehending Comprehension?

This post critically examines whether Section 3d serves as an extension of the inventive step analysis or as a separate requirement under Indian patent law. It discusses the legal and judicial perspectives on TRIPs compliance and the nuanced challenges in pharmaceutical patentability.

Patent Opposition and Revocation: A Presentation

This post examines patent opposition and revocation procedures under Indian law, including pre-grant and post-grant processes. It analyses legal grounds and roles of authorities involved, providing insights through a structured legal perspective.

Working of the Patent Process: A Presentation

This post objectively examines the patent process in India, covering filing, examination, and grant procedures with an emphasis on compliance and deadlines. It serves as a concise guide to the lifecycle of patents under Indian law.

The 3D Effect of Novartis Case on Genetic Inventions

The Novartis case established a strict test for therapeutic efficacy under Section 3(d) of the Indian Patents Act, influencing the patentability of genetic inventions. This post examines the impact on gene sequence patents and the ongoing legal debate regarding their compliance with Indian patent law.